Re-defining T-Cell Exhaustion: Subset, Function, and Regulation

키워드

참고문헌 (120)

1. Hashimoto M, "CD8 T cell exhaustion in chronic infection and cancer : opportunities for interventions", Annu Rev Med, 69, pp.301~318 (2018)
2. Sharma P, "The future of immune checkpoint therapy", Science, 348, pp.56~61 (2015)
3. McLane LM, "CD8 T cell exhaustion during chronic viral infection and cancer", Annu Rev Immunol, 37, pp.457~495 (2019)
4. Zajac AJ, "Viral immune evasion due to persistence of activated T cells without effector function", J Exp Med, 188, pp.2205~2213 (1998)
5. Gallimore A, "Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes", J Exp Med, 187, pp.1383~1393 (1998)
6. Velu V, "Enhancing SIV-specific immunity in vivo by PD-1 blockade", Nature, 458, pp.206~210 (2009)
7. Goepfert PA, "A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon", J Virol, 74, pp.10249~10255 (2000)
8. Shankar P, "Impaired function of circulating HIV-specific CD8(+)T cells in chronic human immunodeficiency virus infection", Blood, 96, pp.3094~3101 (2000)
9. Kostense S, "High viral burden in the presence of major HIV-specific CD8+ T cell expansions : evidence for impaired CTL effector function", Eur J Immunol, 31, pp.677~686 (2001)
10. Lechner F, "Analysis of successful immune responses in persons infected with hepatitis C virus", J Exp Med, 191, pp.1499~1512 (2000)
11. Gruener NH, "Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus", J Virol, 75, pp.5550~5558 (2001)
12. Ye B, "T-cell exhaustion in chronic hepatitis B infection : current knowledge and clinical significance", Cell Death Dis, 6, pp.e1694~ (2015)
13. Mumprecht S, "Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression", Blood, 114, pp.1528~1536 (2009)
14. Schietinger A, "Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis", Immunity, 45, pp.389~401 (2016)
15. Lee PP, "Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients", Nat Med, 5, pp.677~685 (1999)
16. Ahmadzadeh M, "Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired", Blood, 114, pp.1537~1544 (2009)
17. Fourcade J, "PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients", J Immunol, 182, pp.5240~5249 (2009)
18. Matsuzaki J, "Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer", Proc Natl Acad Sci U S A, 107, pp.7875~7880 (2010)
19. Zhang Y, "Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer", Cell Mol Immunol, 7, pp.389~395 (2010)
20. Blackburn SD, "Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection", Nat Immunol, 10, pp.29~37 (2009)
21. Gandhi MK, "Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients", Blood, 108, pp.2280~2289 (2006)
22. Fourcade J, "Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients", J Exp Med, 207, pp.2175~2186 (2010)
23. Barber DL, "Restoring function in exhausted CD8 T cells during chronic viral infection", Nature, 439, pp.682~687 (2006)
24. Day CL, "PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression", Nature, 443, pp.350~354 (2006)
25. Petrovas C, "PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection", J Exp Med, 203, pp.2281~2292 (2006)
26. Trautmann L, "Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction", Nat Med, 12, pp.1198~1202 (2006)
27. Brahmer JR, "Phase I study of single-agent anti-programmed death-1(MDX-1106)in refractory solid tumors : safety, clinical activity, pharmacodynamics, and immunologic correlates", J Clin Oncol, 28, pp.3167~3175 (2010)
28. Topalian SL, "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer", N Engl J Med, 366, pp.2443~2454 (2012)
29. Brahmer JR, "Safety and activity of anti-PD-L1 antibody in patients with advanced cancer", N Engl J Med, 366, pp.2455~2465 (2012)
30. Hargadon KM, "Immune checkpoint blockade therapy for cancer : an overview of FDA-approved immune checkpoint inhibitors", Int Immunopharmacol, 62, pp.29~39 (2018)
31. Page DB, "Immune modulation in cancer with antibodies", Annu Rev Med, 65, pp.185~202 (2014)
32. Pauken KE, "Overcoming T cell exhaustion in infection and cancer", Trends Immunol, 36, pp.265~276 (2015)
33. Im SJ, "Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy", Nature, 537, pp.417~421 (2016)
34. He R, "Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection", Nature, 537, pp.412~428 (2016)
35. Utzschneider DT, "T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections", Immunity, 45, pp.415~427 (2016)
36. Wu T, "The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness", Sci Immunol, 1, pp.eaai8593~ (2016)
37. Blank CU, "Defining ‘T cell exhaustion’", Nat Rev Immunol, 19, pp.665~674 (2019)
38. Kallies A, "Precursor exhausted T cells : key to successful immunotherapy", Nat Rev Immunol, 20, pp.128~136 (2020)
39. Wherry EJ, "Antigen-independent memory CD8 T cells do not develop during chronic viral infection", Proc Natl Acad Sci U S A, 101, pp.16004~16009 (2004)
40. Shin H, "Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection", J Exp Med, 204, pp.941~949 (2007)
41. Utzschneider DT, "T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion", Nat Immunol, 14, pp.603~610 (2013)
42. Speiser DE, "T cell differentiation in chronic infection and cancer : functional adaptation or exhaustion", Nat Rev Immunol, 14, pp.768~774 (2014)
43. Hudson WH, "Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection", Immunity, 51, pp.1043~1058 (2019)
44. Calabro S, "Differential intrasplenic migration of dendritic cell subsets tailors adaptive immunity", Cell Reports, 16, pp.2472~2485 (2016)
45. Eisenbarth SC, "Dendritic cell subsets in T cell programming : location dictates function", Nat Rev Immunol, 19, pp.89~103 (2019)
46. Cyster JG, "Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs", J Exp Med, 189, pp.447~450 (1999)
47. Yamazaki C, "Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1", J Immunol, 190, pp.6071~6082 (2013)
48. Kretzer NM, "RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells", J Exp Med, 213, pp.2871~2883 (2016)
49. Greyer M, "T cell help amplifies innate signals in CD8+ DCs for optimal CD8+ T cell priming", Cell Reports, 14, pp.586~597 (2016)
50. Dorner BG, "Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells", Immunity, 31, pp.823~833 (2009)
51. Kroczek RA, "The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells", Front Immunol, 3, pp.14~ (2012)
52. Helft J, "Cross-presenting CD103+ dendritic cells are protected from influenza virus infection", J Clin Invest, 122, pp.4037~4047 (2012)
53. Borrow P, "Virus-induced immunosuppression : immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression", J Virol, 69, pp.1059~1070 (1995)
54. Mueller SN, "Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection", Proc Natl Acad Sci U S A, 104, pp.15430~15435 (2007)
55. Mueller SN, "PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice", J Clin Invest, 120, pp.2508~2515 (2010)
56. Im SJ, "PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection", Proc Natl Acad Sci U S A, pp.201917298~ (2020)
57. Hamon P, "CX3CR1-dependent endothelial margination modulates Ly6Chigh monocyte systemic deployment upon inflammation in mice", Blood, 129, pp.1296~1307 (2017)
58. Mionnet C, "CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung", Nat Med, 16, pp.1305~1312 (2010)
59. Zhou X, "Differentiation and persistence of memory CD8+ T cells depend on T cell factor 1", Immunity, 33, pp.229~240 (2010)
60. Zhou X, "Cutting edge : generation of memory precursors and functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1", J Immunol, 189, pp.2722~2726 (2012)
61. Gullicksrud JA, "Differential requirements for Tcf1 long isoforms in CD8+ and CD4+ T cell responses to acute viral infection", J Immunol, 199, pp.911~919 (2017)
62. Jeannet G, "Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory", Proc Natl Acad Sci U S A, 107, pp.9777~9782 (2010)
63. Choi YS, "LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6", Nat Immunol, 16, pp.980~990 (2015)
64. Xu L, "The transcription factor TCF-1 initiates the differentiation of TFH cells during acute viral infection", Nat Immunol, 16, pp.991~999 (2015)
65. Wu JQ, "Tcf7 is an important regulator of the switch of self-renewal and differentiation in a multipotential hematopoietic cell line", PLoS Genet, 8, pp.e1002565~ (2012)
66. Tunyaplin C, "Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation", J Immunol, 173, pp.1158~1165 (2004)
67. Ichii H, "Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells", Nat Immunol, 3, pp.558~563 (2002)
68. Ichii H, "Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells", J Immunol, 173, pp.883~891 (2004)
69. Johnston RJ, "Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation", Science, 325, pp.1006~1010 (2009)
70. Yang CY, "The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets", Nat Immunol, 12, pp.1221~1229 (2011)
71. Shaw LA, "Id2 reinforces TH1 differentiation and inhibits E2A to repress TFH differentiation", Nat Immunol, 17, pp.834~843 (2016)
72. Miyazaki M, "The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells", Nat Immunol, 12, pp.992~1001 (2011)
73. Jadhav RR, "Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade", Proc Natl Acad Sci U S A, 116, pp.14113~14118 (2019)
74. Pauken KE, "Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade", Science, 354, pp.1160~1165 (2016)
75. Sen DR, "The epigenetic landscape of T cell exhaustion", Science, 354, pp.1165~1169 (2016)
76. Ghoneim HE, "De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation", Cell, 170, pp.142~157 (2017)
77. Alfei F, "TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection", Nature, 571, pp.265~269 (2019)
78. Khan O, "TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion", Nature, 571, pp.211~218 (2019)
79. Yao C, "Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection", Nat Immunol, 20, pp.890~901 (2019)
80. Mann TH, "Tick-TOX, it's time for T cell exhaustion", Nat Immunol, 20, pp.1092~1094 (2019)
81. Nayar R, "TCR signaling via Tec kinase ITK and interferon regulatory factor 4(IRF4)regulates CD8+ T-cell differentiation", Proc Natl Acad Sci U S A, 109, pp.E2794~ (2012)
82. Nayar R, "Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection", J Immunol, 192, pp.5881~5893 (2014)
83. Man K, "Transcription factor IRF4 promotes CD8+ T cell exhaustion and limits the development of memory-like T cells during chronic infection", Immunity, 47, pp.1129~1141 (2017)
84. Blackburn SD, "Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade", Proc Natl Acad Sci U S A, 105, pp.15016~15021 (2008)
85. Hui E, "T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition", Science, 355, pp.1428~1433 (2017)
86. Kamphorst AO, "Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent", Science, 355, pp.1423~1427 (2017)
87. Zinselmeyer BH, "PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis", J Exp Med, 210, pp.757~774 (2013)
88. Miller BC, "Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade", Nat Immunol, 20, pp.326~336 (2019)
89. Siddiqui I, "Intratumoral Tcf1+ PD-1+ CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy", Immunity, 50, pp.195~211 (2019)
90. Brummelman J, "High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors", J Exp Med, 215, pp.2520~2535 (2018)
91. Sade-Feldman M, "Defining T cell states associated with response to checkpoint immunotherapy in melanoma", Cell, 175, pp.998~1013 (2018)
92. Jansen CS, "An intra-tumoral niche maintains and differentiates stem-like CD8 T cells", Nature, 576, pp.465~470 (2019)
93. Yost KE, "Clonal replacement of tumor-specific T cells following PD-1 blockade", Nat Med, 25, pp.1251~1259 (2019)
94. Scott AC, "TOX is a critical regulator of tumour-specific T cell differentiation", Nature, 571, pp.270~274 (2019)
95. Wang X, "TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma", J Hepatol, 71, pp.731~741 (2019)
96. Seo H, "TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion", Proc Natl Acad Sci U S A, 116, pp.12410~12415 (2019)
97. Kim CG, "VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers", Sci Immunol, 4, pp.eaay0555~ (2019)
98. Chen J, "NR4A transcription factors limit CAR T cell function in solid tumours", Nature, 567, pp.530~534 (2019)
99. Shin B, "Effector CD4 T cells with progenitor potential mediate chronic intestinal inflammation", J Exp Med, 215, pp.1803~1812 (2018)
100. Karmaus PW, "Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity", Nature, 565, pp.101~105 (2019)
101. Elsaesser H, "IL-21 is required to control chronic viral infection", Science, 324, pp.1569~1572 (2009)
102. Yi JS, "A vital role for interleukin-21 in the control of a chronic viral infection", Science, 324, pp.1572~1576 (2009)
103. Fröhlich A, "IL-21R on T cells is critical for sustained functionality and control of chronic viral infection", Science, 324, pp.1576~1580 (2009)
104. Fraietta JA, "Determinants of response and resistance to CD19 chimeric antigen receptor(CAR)T cell therapy of chronic lymphocytic leukemia", Nat Med, 24, pp.563~571 (2018)
105. Klebanoff CA, "Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy", JCI Insight, 2, pp.e95103~ (2017)
106. Klebanoff CA, "Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy", J Clin Invest, 126, pp.318~334 (2016)
107. Crompton JG, "Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy", Immunol Rev, 257, pp.264~276 (2014)
108. Hinrichs CS, "Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity", Proc Natl Acad Sci U S A, 106, pp.17469~17474 (2009)
109. Jin HT, "Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection", Proc Natl Acad Sci U S A, 107, pp.14733~14738 (2010)
110. West EE, "PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells", J Clin Invest, 123, pp.2604~2615 (2013)
111. Penaloza-MacMaster P, "Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection", J Exp Med, 211, pp.1905~1918 (2014)
112. Ha SJ, "Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection", J Exp Med, 205, pp.543~555 (2008)
113. Peng W, "Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer", OncoImmunology, 2, pp.e22691~ (2013)
114. Duraiswamy J, "Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors", Cancer Res, 73, pp.3591~3603 (2013)
115. Johnston RJ, "The immunoreceptor TIGIT regulates antitumor and antiviral CD8+ T cell effector function", Cancer Cell, 26, pp.923~937 (2014)
116. Sakuishi K, "Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity", J Exp Med, 207, pp.2187~2194 (2010)
117. Anderson AC, "Lag-3, Tim-3, and TIGIT : co-inhibitory receptors with specialized functions in immune regulation", Immunity, 44, pp.989~1004 (2016)
118. Brooks DG, "IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection", Proc Natl Acad Sci U S A, 105, pp.20428~20433 (2008)
119. Angelosanto JM, "Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection", J Virol, 86, pp.8161~8170 (2012)
120. Ribeiro SP, "The CD8+ memory stem T cell(TSCM)subset is associated with improved prognosis in chronic HIV-1 infection", J Virol, 88, pp.13836~13844 (2014)

관련 논문AI추천